Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Pierre Fabre Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom New Jersey California

View original content:https://www.prnewswire.co.uk/news-releases/atara-biotherapeutics-and-pierre-fabre-laboratories-announce-publication-of-phase-3-allele-tab-cel-data-in-the-lancet-oncology-302049771.html